Skip to Content

RDY 614 (Pramipexole dihydrochloride extended-release 3 mg)

Pill imprint RDY 614 has been identified as Pramipexole dihydrochloride extended-release 3 mg.

Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 3 mg is not a controlled substance under the Controlled Substance Act (CSA).

Pramipexole dihydrochloride extended-release 3 mg RDY 614
Discount Card Promo
Pramipexole dihydrochloride extended-release
RDY 614
3 mg
Elliptical / Oval
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Dr. Reddy's Laboratories Limited

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.